Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project
March 11 (Reuters) - Ryvu Therapeutics SA RVU.WA: SIGNS GRANT AGREEMENT WITH POLAND'S NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT (NCBR) FOR PERO PROJECT TOTAL NET VALUE OF PERO PROJECT IS PLN 32.35 MILLION, RECOMMENDED GRANT FUNDING FOR PERO PROJECT IS PLN 19.96 MILLION Source text: ID:nEM2q7rHPa Further company coverage: RVU.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys